• ICPerMed
  • Activities
  • Services
  • Internal

  • picture

    ICPerMed "Best Practice in Personalised Medicine" Award 2018

    Call for Applications

    ICPerMed "Best Practice in Personalised Medicine"Award 2018

    Submission deadline for applications: closed

    ICPerMed Secretariat

    1.    General call description

    The 2018 Award aims to recognise, encourage, promote and disseminate outstanding examples of best practices in personalised medicine. Individuals who have published scientific papers and/or developed best practice strategies in the field of PM between January 1st, 2016 and December 31st, 2017, from any of the ICPerMed partner countries, are eligible to apply.

    The launch of the Award was on 19th of January and the deadline for proposal submission closed on 2nd March, 2018.

    The awardee(s) will be invited to the ICPerMed Conference 2018 and will be given the opportunity to present their results during a plenary session to stakeholders interested in the area of PM.  
    In addition, the successful candidates will receive a non-cash award of € 500,00 (five hundred) to support the dissemination of the awarded best practice example.

    2.    Topic of the call

    The program will be centred on selecting Best Practices in Personalised Medicine (PM). These best practice examples can consist of one or several of the following:

    1. Scientific paper focused on novel approaches for the implementation of PM
    2. Training programmes for health personnel, increasing the level of awareness on the potential of PM
    3. Examples for interdisciplinary or intersectoral groups of collaboration (governmental and non-governmental organizations, academic management, medical research and Health Care), for the implementation of PM, including Ethical, Legal and Social Issues (ELSI) activities.

    Number of awards:

    A maximum number of three awards will be selected.

    3.    Criteria Eligibility

    • Applicants have to be residents of an ICPerMed partner countries
    • They have to be responsible (e.g. coordinator) for a best practise strategy in PM
    • Applicants should belong to one of the following groups:
      • Researchers professional in a discipline connected to PM, e.g. Biomedical Sciences and Clinical Research, ELSA-research, regulatory sciences or HTA-connected Research,
      • Representatives of Patient organisations,
      • Representatives of health care providers and insurances,
      • Health Care Professionals, like nurses and GPs,
      • Medical Education Professionals.

    4.    Application


    5.    Evaluation

    5.1- Proposal Evaluation:

    Proposals will be evaluated in a one-stage process by the ICPerMed Steering Board (SB)and a selection of researchers experienced in the topic propose will support in the scientific  evaluation with final approval by  the ICPerMed Executive Committee.
    The proposals will be evaluated on the following criteria:

    1.- Knowledge Production

    • Peer reviewed publications and citations
    • Other publications such as books, book chapters, editorials or bulletins
    • Presentations to national and international conferences
    • Research reports and ‘grey literature’ produced
    • Cochrane systematic reviews produced

    2.- Research capacity-building and targeting

    • Education and training of personnel such as clinicians, health professionals and scientists
    • Higher degrees, such as PhD, obtained by research personnel
    • Research personnel attracted from overseas and retention of personnel
    • Spin-off projects developed and further research funding leveraged
    • Development and use of novel research techniques
    • Establishment of new datasets, databases or research data lodged in national database
    • New national/international collaborations or strategic partnerships formed with other research teams, industrial partners or health agencies
    • Internationalization of research: Involvement of researchers with different European origin and global health research initiatives

    3.- Informing policy and practice

    • Dissemination and knowledge-transfer events or networks established with research ‘users’ such as policy-makers and health professionals
    • Advisory roles of involved researchers to government and policy-makers
    • Commissioned reports from government departments or agencies
    • Policy briefing papers, practical handbooks and other grey material disseminated to research users
    • Contribution of research to clinical treatment or best practice guidelines
    • Public outreach and dissemination through media and other

    4.- Population health and health sector benefits

    • Contribution of respective research to health promotion initiatives
    • Randomized control trials completed and new interventions established as a result
    • Numbers of patients enrolled on clinical trials or engaged with studies undertaken in clinical research facilities
    • Contribution of respective research to actual health benefits for the general public
    • Savings to the health system through gains in health service efficiency, improved    primary care or introduction of preventative health measures, where the respective research/personnel contributed to this
    • Reduced health inequalities in health status and healthcare through where respective research/personnel contributed to this
    • Increased availability of local pool of evidence and evidence “generators” to health policy-makers and health practitioners on the regional, national, European and/or international level

    5.-Economic impacts

    • Patents, invention disclosures and other IP applications and award of commercialization support grants to develop marketable products
    • Licence agreements and revenues generated as a result
    • Spin-out companies formed and employment gained  
    • Success of involved personnel in attaining international research funding, for example though EU Framework Programmes
    • Success of involved research facilities and centres in attracting and maintaining PhD-qualified research workforce
    • Proxy measures of enhanced international reputation of participating partners and their respective countries for health research (e.g. by attracting pharma industry R&D; formal collaborative partnerships developed between researchers and industry)
    • Economic GDP gains from improved patient care and population health where link to the respective research/study can be established

    Total Score: 1-5 for every criteria. High score if the application covers more than one topic
    Based on the evaluation, the highest ranking proposal for each topic will be awarded the prize.
    These resumes will be published via ICPerMed dissemination channels.

    5.2- Dissemination Scheme

    The objective of this award is to encourage and disseminate best practice examples in personalised medicine.
    The winner(s) will be invited to the ICPerMed 2018 conference and will be given the opportunity to present their results during a plenary session. In addition, the successful candidates will receive support for the dissemination of the best practice example by the ICPerMed Secretariat in the value of €.500,00 (five hundred).

    The aim of this dissemination is to provide the winner with an opportunity to seek supplementary dissemination activities that will accelerate and maximize the potential impact of the research findings and learning gained on best practice on PM.
    The dissemination responsibility will be centred on ICPerMed.
    The package of dissemination will be aligned with the current stage of the research process and with the target audience/s.
    List of activities of dissemination: (Activities not exhaustive and there is no intent to imply that applications for these types of activities will be more successful than for activities not captured in the list.)

    • Abstracts of these winner’s talk(s) during the ICPerMed conference will be published in the conference report, and the talk(s) will be made available on the ICPerMed website
    • Development of new educational material/sessions
    • Development of an outreach campaign using media such as television, radio or print
    • Use of tools such as information brochures, plain language summaries, newsletters or policy briefs
    • Use of online technologies such as websites, podcasts, webinars, YouTube
    • Development of a broader knowledge exchange strategy for the current award
    • Development and organization of linkage and exchange activities (meetings, workshops or seminars) that are specifically targeted at knowledge users
    • Any combination of the above or related activities.

    6.    Award Presentation

    The winner will be invited as a special ICPerMed lecturer in the Berlin Conference 2018 (November, 20-21th). The travel costs related to the lecture will be covered by ICPerMed.

    7.    Call Schedule

    Preliminary Announcement: December 2017
    Announcement of the call: 19th January 2018
    Deadline for proposal submission: closed on 2nd March 2018
    Deadline evaluation Steering Board of the proposals: 30th March 2018
    Decisions and information about the evaluation results: Last week of April 2018
    Award Presentation Ceremony Berlin: 20-21th November 2018